Jiangsu Jibeier Pharmaceutical Co., Ltd. (SHA:688566)
China
· Delayed Price · Currency is CNY 30.41
+0.55 (1.84%)
Mar 10, 2026, 3:00 PM CST
SHA:688566 Revenue
In the year 2025, Jiangsu Jibeier Pharmaceutical had annual revenue of 964.93M CNY with 7.63% growth. Jiangsu Jibeier Pharmaceutical had revenue of 260.50M in the quarter ending December 31, 2025, with 2.83% growth.
Revenue
964.93M
Revenue Growth
+7.63%
P/S Ratio
6.29
Revenue / Employee
727.15K
Employees
1,326
Market Cap
6.06B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 964.93M | 68.40M | 7.63% |
| Dec 31, 2024 | 896.53M | 35.60M | 4.14% |
| Dec 31, 2023 | 860.93M | 206.20M | 31.49% |
| Dec 31, 2022 | 654.73M | 145.04M | 28.46% |
| Dec 31, 2021 | 509.69M | -56.28M | -9.94% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chongqing Pharscin Pharmaceutical | 786.51M |
| Hunan Warrant Pharmaceutical Co.,Ltd | 1.52B |
| Zhejiang Sunflower Great Health | 302.92M |
| Shanxi Zhendong Pharmaceutical Co.,Ltd | 2.92B |
| ChengDu ShengNuo Biotec | 741.34M |
| Teyi Pharmaceutical Group Co.,Ltd | 924.04M |
| Tianjin Lisheng Pharmaceutical | 1.32B |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 1.45B |